Apomorphine

73 interactions 4 explained in plain English
Also sold as: Apokyn Kynmobi Onapgo
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Jul 4, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Dolasetron Injection Palonosetron Injection Dolasetron Granisetron Transdermal Patch Granisetron Injection Galantamine
5 Contraindicated 63 Major 5 Moderate
All (73) Contraindicated (5) Major (63) Moderate (5)

Contraindicated

Apomorphine Dolasetron Anzemet Increased risk of profound hypotension and altered consciousness and an increased risk of QT interval prolongation, associated wit... Details Apomorphine Dolasetron Injection Anzemet Increased risk of profound hypotension and altered consciousness and an increased risk of QT interval prolongation, associated wit... Details Apomorphine Granisetron Transdermal Patch Sancuso Increased risk of profound hypotension and altered consciousness and an increased risk of QT interval prolongation, associated wit... Details Apomorphine Granisetron Injection Granisol Increased risk of profound hypotension and altered consciousness and an increased risk of QT interval prolongation, associated wit... Details Apomorphine Palonosetron Injection Aloxi® Increased risk of profound hypotension and altered consciousness Details

Major

Apomorphine Amitriptyline Elavil Explained An increased risk of QT interval prolongation Details Apomorphine Sertraline Explained An increased risk of QT interval prolongation Details Apomorphine Buprenorphine Belbuca Explained An increased risk of QT interval prolongation Details Apomorphine Relugolix Orgovyx Explained Increased risk of QT interval prolongation Details Apomorphine Amisulpride Injection Barhemsys Reduced apomorphine efficacy and increased risk of QT interval prolongation Details Apomorphine Arsenic Trioxide Trisenox An increased risk of QT interval prolongation Details Apomorphine Aripiprazole Injection Abilify An increased risk of QT interval prolongation Details Apomorphine Arsenic Trioxide Injection Trisenox An increased risk of QT interval prolongation Details Apomorphine Asenapine Transdermal Patch Secuado An increased risk of QT interval prolongation Details Apomorphine Azithromycin AzaSite An increased risk of QT interval prolongation Details Apomorphine Alfuzosin UroXatral An increased risk of QT interval prolongation Details Apomorphine Anagrelide Agrylin Increased risk of QT interval prolongation Details Apomorphine Bedaquiline Sirturo Increased risk of QT interval prolongation Details Apomorphine Chloroquine Aralen® An increased risk of QT interval prolongation Details Apomorphine Dasatinib Phyrago An increased risk of QT interval prolongation Details Apomorphine Degarelix Injection Firmagon Increased risk of QT interval prolongation Details Apomorphine Deutetrabenazine Austedo An increased risk of QT interval prolongation Details Apomorphine Disopyramide Norpace An increased risk of QT interval prolongation Details Apomorphine Dofetilide Tikosyn An increased risk of QT interval prolongation Details Apomorphine Encorafenib Braftovi Increased risk of QT interval prolongation Details Apomorphine Entacapone Comtan An increased risk of tachycardia, hypertension, and arrhythmias Details Apomorphine Entrectinib Rozlytrek An increased risk of QT interval prolongation Details Apomorphine Eribulin Injection Halaven Increased risk of QT interval prolongation Details Apomorphine Famotidine Calmicid Increased risk of QT interval prolongation Details Apomorphine Famotidine Injection Calmicid Increased risk of QT interval prolongation Details Apomorphine Felbamate Felbatol Increased risk of QT interval prolongation Details Apomorphine Fexofenadine Allegra Decreased apomorphine efficacy Details Apomorphine Flecainide Tambocor® An increased risk of QT interval prolongation Details Apomorphine Foscarnet Injection Foscavir Increased risk of QT interval prolongation Details Apomorphine Fostemsavir Rukobia Increased risk of torsade de pointes Details Apomorphine Galantamine Razadyne Increased risk of QT interval prolongation Details Apomorphine Gatifloxacin Ophthalmic Zymar® An increased risk of QT interval prolongation Details Apomorphine Gemifloxacin Factive An increased risk of QT interval prolongation Details Apomorphine Glasdegib Daurismo Increased risk of QT interval prolongation Details Apomorphine Goserelin Implant Zoladex Increased risk of QT interval prolongation Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.